Clinical Trial Update: Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

MeiraGTx reports long-term follow-up data for glutamic acid decarboxylase gene transfer being studied in Parkinson's disease in Phase 1/2 trials (status: active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• GAD gene transfer

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING